Ohr Releases New Interim Data On Squalamine Eye Drops

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Friday, August 22, 2014

Comments

Ocular Surgery News

Ohr Pharmaceuticals reported additional interim data from its phase 2 study on Squalamine eye drops for the treatment of wet age-related macular degeneration.

Full Abstract

Which type of cataract is associated with an increased risk of capsular rupture during surgery?
1. posterior polar
2. sutural
3. anterior subcapsular
4. posterior subcapsular
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Ohr Releases New Interim Data On Squalamine Eye Drops

Comments

Quick Quiz

Which type of cataract is associated with an increased risk of capsular rupture during surgery?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us